Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Human medicine
Name of medicinal product: CETIRIZIN ACTAVIS
Active substances:
Estonian, English, Latin
ATC code: R06AE07
Dosage form: film-coated tablet
Strength: 10mg
Legal status for supply*: Not subject to medicinal prescription, Subject to medicinal prescription
Summary of product characteristics (SPC):  (last updated June 8, 2023)
Package information leaflet (PIL): EST  (last updated June 1, 2023)
Translation of package information leaflet into Russian: RUS  (last updated June 16, 2022)
Translation of package information leaflet into English: ENG  (last updated June 16, 2022)
Labelling:  (last updated June 8, 2023)
Indication: Symptomatic treatment of allergic rhinitis and conjunctivitis. Symptomatic treatment of urticaria.
Safety features: Requiered on some packages, click on package code at the end of the page for more information
Marketing authorization holder: Teva B.V. 
Marketing authorization number: 389302 
Marketing authorization issued on: August 24, 2007 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: National 
Assessment report:   
Description Additional condition
Hambaarstil on õigus välja kirjutada
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1098907  CETIRIZIN ACTAVIS  film-coated tablet  10mg 10TK  OTC      19.02.2024     
1098918  CETIRIZIN ACTAVIS  film-coated tablet  10mg 30TK  Prescription  50% 100%  4,50  19.02.2024     
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere